ReviewFamilial cancer2023

Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature.

Ketty Hu-Heimgartner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.